These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

23 related articles for article (PubMed ID: 10904191)

  • 1. Comparison of three nucleic acid amplification tests for detection of Chlamydia trachomatis in urine specimens.
    Gaydos CA; Theodore M; Dalesio N; Wood BJ; Quinn TC
    J Clin Microbiol; 2004 Jul; 42(7):3041-5. PubMed ID: 15243057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of roche COBAS Amplicor assay for detection of Chlamydia trachomatis in rectal and pharyngeal specimens by an omp1 PCR assay.
    Lister NA; Tabrizi SN; Fairley CK; Garland S
    J Clin Microbiol; 2004 Jan; 42(1):239-41. PubMed ID: 14715759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chlamydia trachomatis infection and associated risk factors in a low-income marginalized urban population in coastal Peru.
    León SR; Konda KA; Klausner JD; Jones FR; Cáceres CF; Coates TJ;
    Rev Panam Salud Publica; 2009 Jul; 26(1):39-45. PubMed ID: 19814880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The laboratory diagnosis of Chlamydia trachomatis infections.
    Chernesky MA
    Can J Infect Dis Med Microbiol; 2005 Jan; 16(1):39-44. PubMed ID: 18159527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of rRNA-based and DNA-based nucleic acid amplifications for detection of Chlamydia trachomatis, Neisseria gonorrhoeae, and Ureaplasma urealyticum in urogenital swabs.
    Liang Y; Jin X; Yuan F; Li Z; Chen S
    BMC Infect Dis; 2018 Dec; 18(1):651. PubMed ID: 30541468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of an rRNA-based and DNA-based nucleic acid amplification test for the detection of Chlamydia trachomatis in trachoma.
    Yang JL; Schachter J; Moncada J; Habte D; Zerihun M; House JI; Zhou Z; Hong KC; Maxey K; Gaynor BD; Lietman TM
    Br J Ophthalmol; 2007 Mar; 91(3):293-5. PubMed ID: 17050583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specimen processing and concentration of Chlamydia trachomatis added can influence false-negative rates in the LCx assay but not in the APTIMA Combo 2 assay when testing for inhibitors.
    Chong S; Jang D; Song X; Mahony J; Petrich A; Barriga P; Chernesky M
    J Clin Microbiol; 2003 Feb; 41(2):778-82. PubMed ID: 12574282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic review of the clinical effectiveness and cost-effectiveness of rapid point-of-care tests for the detection of genital chlamydia infection in women and men.
    Hislop J; Quayyum Z; Flett G; Boachie C; Fraser C; Mowatt G
    Health Technol Assess; 2010 Jun; 14(29):1-97, iii-iv. PubMed ID: 20557810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of Chlamydia trachomatis in symptomatic and asymptomatic populations with urogenital specimens by AMP CT (Gen-probe incorporated) compared to others commercially available amplification assays.
    de Barbeyrac B; Géniaux M; Hocké C; Dupon M; Bébéar C
    Diagn Microbiol Infect Dis; 2000 Jul; 37(3):181-5. PubMed ID: 10904191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of three commercially available amplification assays, AMP CT, LCx, and COBAS AMPLICOR, for detection of Chlamydia trachomatis in first-void urine.
    Goessens WH; Mouton JW; van der Meijden WI; Deelen S; van Rijsoort-Vos TH; Lemmens-den Toom N; Verbrugh HA; Verkooyen RP
    J Clin Microbiol; 1997 Oct; 35(10):2628-33. PubMed ID: 9316920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of performances of two commercially available tests, a PCR assay and a ligase chain reaction test, in detection of urogenital Chlamydia trachomatis infection.
    Puolakkainen M; Hiltunen-Back E; Reunala T; Suhonen S; Lähteenmäki P; Lehtinen M; Paavonen J
    J Clin Microbiol; 1998 Jun; 36(6):1489-93. PubMed ID: 9620366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison between the LCx Probe system and the COBAS AMPLICOR system for detection of Chlamydia trachomatis and Neisseria gonorrhoeae infections in patients attending a clinic for treatment of sexually transmitted diseases in Amsterdam, The Netherlands.
    van Doornum GJ; Schouls LM; Pijl A; Cairo I; Buimer M; Bruisten S
    J Clin Microbiol; 2001 Mar; 39(3):829-35. PubMed ID: 11230391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multicenter evaluation of the fully automated COBAS AMPLICOR PCR test for detection of Chlamydia trachomatis in urogenital specimens.
    Vincelette J; Schirm J; Bogard M; Bourgault AM; Luijt DS; Bianchi A; van Voorst Vader PC; Butcher A; Rosenstraus M
    J Clin Microbiol; 1999 Jan; 37(1):74-80. PubMed ID: 9854067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of manual Amplicor PCR, Cobas Amplicor PCR, and LCx assays for detection of Chlamydia trachomatis infection in women by using urine specimens.
    Pasternack R; Vuorinen P; Pitkäjärvi T; Koskela M; Miettinen A
    J Clin Microbiol; 1997 Feb; 35(2):402-5. PubMed ID: 9003605
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.